AU2001243617A1 - Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection - Google Patents
Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejectionInfo
- Publication number
- AU2001243617A1 AU2001243617A1 AU2001243617A AU4361701A AU2001243617A1 AU 2001243617 A1 AU2001243617 A1 AU 2001243617A1 AU 2001243617 A AU2001243617 A AU 2001243617A AU 4361701 A AU4361701 A AU 4361701A AU 2001243617 A1 AU2001243617 A1 AU 2001243617A1
- Authority
- AU
- Australia
- Prior art keywords
- modulate
- agents
- activity
- combination
- allograft rejection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18916500P | 2000-03-14 | 2000-03-14 | |
US60189165 | 2000-03-14 | ||
PCT/US2001/008015 WO2001068132A1 (en) | 2000-03-14 | 2001-03-13 | Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001243617A1 true AU2001243617A1 (en) | 2001-09-24 |
Family
ID=22696204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001243617A Abandoned AU2001243617A1 (en) | 2000-03-14 | 2001-03-13 | Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020071839A1 (en) |
AU (1) | AU2001243617A1 (en) |
WO (1) | WO2001068132A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7304149B2 (en) * | 2002-06-20 | 2007-12-04 | Washington University In St. Louis | BTLA nucleic acids |
PL2344540T3 (en) | 2008-10-02 | 2018-05-30 | Aptevo Research And Development Llc | Cd86 antagonist multi-target binding proteins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2292415A1 (en) * | 1997-06-20 | 1998-12-30 | Innogenetics N.V. | B7-binding molecules for treating immune diseases |
PL350909A1 (en) * | 1999-02-12 | 2003-02-10 | Genetics Inst | Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
-
2001
- 2001-03-13 US US09/805,801 patent/US20020071839A1/en not_active Abandoned
- 2001-03-13 AU AU2001243617A patent/AU2001243617A1/en not_active Abandoned
- 2001-03-13 WO PCT/US2001/008015 patent/WO2001068132A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001068132A1 (en) | 2001-09-20 |
US20020071839A1 (en) | 2002-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI318207B (en) | Carbamate caspase inhibitors and uses thereof | |
AU1897700A (en) | Removable stent | |
AU3620600A (en) | Skin-marking devices and their use | |
SG86414A1 (en) | Sanitary tampon | |
AU2820000A (en) | Assembly of a cleansing device and one or more cleansing elements | |
MXPA03004714A (en) | Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents. | |
AU2001268197A1 (en) | Human pancreatic islet glucose-6-phosphatase | |
AU1752901A (en) | Articulating earplug | |
AU2460100A (en) | Masking agent | |
AU5493400A (en) | Absorbent airlaid structure | |
ZA200102956B (en) | Use of ophthalmic composition comprising vitamin A and Vitamin E. | |
AU2001276149A1 (en) | Cleaning and disinfecting agent | |
IL151589A0 (en) | New combination of a betablocker and a cholestrol-lowering agent | |
AU2001270129A1 (en) | Human phosphodiesterases | |
AU3328600A (en) | Ocular tension-lowering agents | |
AU140179S (en) | Earplug dispenser | |
AU2501200A (en) | Human peptidases | |
AU2001243617A1 (en) | Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection | |
AU1056399A (en) | Sanitary devices and a toilet | |
AU4432001A (en) | Trityl-type compounds and their use | |
AU2001241875A1 (en) | Human dynamin 40322 | |
GB0021497D0 (en) | Compounds and their use | |
AU2001249182A1 (en) | Use of rapamycin and agents that inhibit b7 activity in immunomodulation | |
AU2529501A (en) | Macrocyclic compounds and their use | |
AU2001218611A1 (en) | Stent |